abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

5T4
Back
Total number of drugs
42
Phase II and later clinical stages
7.1%
Involving companies
39
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
Anti-5T4 nanobody (Novamab Biopharma)Anti-5T4 nanobody (Novamab Biopharma)NanobodyNeoplasms Hemic and Lymphatic DiseasesTrophoblast glycoprotein inhibitorsShanghai Novamab Biopharmaceuticals Co., Ltd.Shanghai Novamab Biopharmaceuticals Co., Ltd.DiscoveryDiscoveryAnti-5T4 nanobody (Novamab Biopharma)
detail  >
Anatumomab mafenatoxAnatumomab mafenatoxFab fragmentNeoplasms Digestive System Disorders Endocrinology and Metabolic Disease Respiratory Diseases Urogenital DiseasesTrophoblast glycoprotein inhibitors Tumor-associated glycoprotein 72 inhibitorsActive Biotech ABDiscontinuedAnatumomab mafenatox
detail  >
5T4(Zonsen Peplib Biotech)5T4(Zonsen Peplib Biotech)Peptide drug conjugatesNeoplasmsTrophoblast glycoprotein modulatorsZonsen Peplib Biotech Co., Ltd.DiscoveryDiscovery5T4(Zonsen Peplib Biotech)
detail  >
ZV-0501ZV-0501Antibody drug conjugate (ADC) ADCNeoplasms Endocrinology and Metabolic Disease Urogenital DiseasesTrophoblast glycoprotein inhibitors Tubulin inhibitorsZhejiang Zova Biotherapeutics,Inc.Zhejiang Zova Biotherapeutics,Inc.DiscoveryDiscoveryMMAF MafodotinZV-0501
detail  >
WO2024197151WO2024197151Bispecific antibodyNeoplasmsSalubris Biotherapeutics, Inc.Salubris Biotherapeutics, Inc.DiscoveryWO2024197151
detail  >
AVA-020AVA-020Recombinant proteinNeoplasmsTrophoblast glycoprotein modulatorsAvacta Group PlcAvacta Group PlcDiscoveryAVA-020
detail  >
n501-SN38n501-SN38Antibody drug conjugate (ADC) ADCNeoplasmsTrophoblast glycoprotein modulators DNA topoisomerase I inhibitorsFudan UniversityFudan UniversityPreclinicalPreclinicalCL2ASN38n501-SN38
detail  >
m603-MMAEm603-MMAEAntibody drug conjugate (ADC) ADCNeoplasms Digestive System Disorders Endocrinology and Metabolic DiseaseTrophoblast glycoprotein inhibitors Tubulin inhibitorsFudan UniversityFudan UniversityPreclinicalPreclinicalMMAE 甲基澳瑞他汀Em603-MMAE
detail  >
MEDI-0641MEDI-0641Antibody drug conjugate (ADC) ADCNeoplasmsTrophoblast glycoprotein inhibitors DNA inhibitorsMedImmune LLCMedImmune LLCPreclinicalPyrrolobenzodiazepine2MEDI-0641cysteinyl 半胱氨酸
detail  >
ChAdOx1 MVA 5T4 vaccine (Vaccitech)ChAdOx1 MVA 5T4 vaccine (Vaccitech)Therapeutic vaccineNeoplasms Urogenital DiseasesTrophoblast glycoprotein inhibitorsBarinthus Biotherapeutics (UK) Ltd.Phase 2ChAdOx1 MVA 5T4 vaccine (Vaccitech)
detail  >
Total 42 data
1
2
3
4
5